S
Supernus Pharmaceuticals (SUPN)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (exten... Read more
- USD32.71
- USD33.80
- USD32.55
- USD40.28
- -1.80%
- 668M
- 875.18k
- 636.10k
- 1.8B
- 27.05
- 22.40%
- 15.90%
Stock News
yesterday
Levi's CEO Michelle Gass says strong international business helps ward off tariff impact
CNBC
yesterday
Nvidia officially gets its $4 trillion finish. Here’s what could come next.
MarketWatch
yesterday
Levi Strauss raises sales guidance, says it will absorb some tariff costs for now
CNBC
yesterday
Business class+? Delta says segmentation is coming to high-end cabins
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
